Evidence map›Paper›PMID 26226017›Full record

ArticlePloS one2015

A Report of At-Scale Distribution of Chlorhexidine Digluconate 7.1% Gel for Newborn Cord Care to 36,404 Newborns in Sokoto State, Nigeria: Initial Lessons Learned.

Nosakhare Orobaton, Dele Abegunde, Kamil Shoretire, Jumare Abdulazeez, Bolaji Fapohunda, Goli Lamiri, Abubakar Maishanu, Akeem Ganiyu, Eric Ndifon, Ringpon Gwamzhi and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Nosakhare OrobatonUnited States Agency for International Development/Targeted States High Impact Project, Sokoto Nigeria; John Snow, Inc. Research & Training Institute, Boston, MA, United States of America.
Dele AbegundeUnited States Agency for International Development/Targeted States High Impact Project, Sokoto Nigeria; John Snow, Inc. Research & Training Institute, Boston, MA, United States of America.
Kamil ShoretireUnited States Agency for International Development/Targeted States High Impact Project, Sokoto Nigeria; Jhpiego, Baltimore, MD, United States of America.
Jumare AbdulazeezUnited States Agency for International Development/Targeted States High Impact Project, Sokoto Nigeria; John Snow, Inc. Research & Training Institute, Boston, MA, United States of America.
Bolaji FapohundaUnited States Agency for International Development/Targeted States High Impact Project, Sokoto Nigeria; John Snow, Inc. Research & Training Institute, Boston, MA, United States of America.
Goli LamiriEuropean Union Support to Immunization Governance in Nigeria (EU-SIGN Project), Abuja, Nigeria.
Abubakar MaishanuUnited States Agency for International Development/Targeted States High Impact Project, Sokoto Nigeria; John Snow, Inc. Research & Training Institute, Boston, MA, United States of America.
Akeem GaniyuUnited States Agency for International Development/Targeted States High Impact Project, Sokoto Nigeria; John Snow, Inc. Research & Training Institute, Boston, MA, United States of America.
Eric NdifonUnited States Agency for International Development/Targeted States High Impact Project, Sokoto Nigeria; John Snow, Inc. Research & Training Institute, Boston, MA, United States of America.
Ringpon GwamzhiUnited States Agency for International Development/Targeted States High Impact Project, Sokoto Nigeria; John Snow, Inc. Research & Training Institute, Boston, MA, United States of America.
Matthew Osborne-SmithPartners in Health, Boston, MA, United States of America.
John Snow (United States) · USTarget (United States) · USPartners In Health · USUnited States Agency for International Development · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWith an annual estimated 276,000 neonatal deaths, Nigeria has the second highest of any country in the world. Global progress in accelerating neonatal deaths is hinged to scaled-up interventions in Nigeria. We used routine data of chlorhexidine digluconate 7.1% gel utilized by 36,404 newborns delivered by 36,370 mothers, to study lessons associated with at-scale distribution in Sokoto State, North West Nigeria. METHODS AND

findingsUnder state government leadership, a community-based distribution system overseen by 244 ward development committees and over 3,440 community-based health volunteers and community drug keepers, was activated to deliver two locally stored medicines to women when labor commenced. Newborns and their mothers were tracked through 28 days and 42 days respectively, including verbal autopsy results. 36,404 or 26.3% of expected newborns received the gel from April 2013 to December 2013 throughout all 244 wards in the State. 99.97% of newborns survived past 28 days. There were 124 pre-verified neonatal deaths reported. Upon verification using verbal autopsy procedures, 76 deaths were stillborn and 48 were previously live births. Among the previous 48 live births, the main causes of death were sepsis (40%), asphyxia (29%) and prematurity (8%). Underuse of logistics management information by government in procurement decisions and not accounting for differences in LGA population sizes during commodity distribution, severely limited program scalability.

conclusionsEnhancements in the predictable availability and supply of chlorhexidine digluconate 7.1% gel to communities through better, evidence-based logistics management by the state public sector will most likely dramatically increase program scalability. Infections as a cause of mortality in babies delivered in home settings may be much higher than previously conceived. In tandem with high prevalence of stillborn deaths, delivery, interventions designed to increase mothers' timely and regular use of quality antenatal care, and increased facility-based based delivery, need urgent attention. We call for accelerated investments in community health volunteer programs and the requisite community measurement systems to better track coverage. We also advocate for the development, refinement and use of routine community-based verbal autopsies to track newborn and maternal survival.

Indexed as

Infant MortalityAnti-Infective Agents, LocalCause of DeathChlorhexidineFemaleGelsHumansInfantInfant, NewbornNigeriaPerinatal CarePregnancyUmbilical CordAnti-Infective Agents, LocalChlorhexidinechlorhexidine gluconateGels

Identifiers

PMID26226017
PMCPMC4520693
OpenAlexW1670698163

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.